Nucleai and Sirona Dx to provide new proteomics solution for pharma companies
Under the partnership, Sirona Dx oversees assay design, development and validation, ensuring quality image production.
Drug Development
Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study
Adcendo secures $75m in Series C funding for ADC development
Lilly to acquire CrossBridge Bio for up to $300m
Travere Therapeutics gains FDA approval for sparsentan in FSGS
MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority
Telix and Regeneron sign $4.3bn deal to co-develop radiopharmaceutical therapies
Roche and C4 Therapeutics to advance degrader-antibody conjugates research
